Prevalence and determinants of iron deficiency in cardiac amyloidosis-Reference-Cited by-同舟云学术

Prevalence and determinants of iron deficiency in cardiac amyloidosis

Published:2022-02-06 Issue:2 Volume:9 Page:1314-1327
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Jobbé‐Duval Antoine¹,Bézard Mélanie²,Moutereau Stéphane³,Kharoubi Mounira²,Oghina Silvia²,Zaroui Amira²,Galat Arnault²,Chalard Coraline²,Hugon‐Vallet Elisabeth¹,Lemonnier Francois⁴,Eyharts Damien²,Poulot Elsa⁵,Fanen Pascale⁶,Funalot Benoit⁶,Molinier‐Frenkel Valérie⁷,Audard Vincent⁸,Hittinger Luc²,Delbarre Marc Antoine²,Teiger Emmanuel²,Damy Thibaud²^ORCID

Affiliation:

1. Heart Failure and Transplant Department ‘Louis Pradel’ Cardiologic Hospital, Hospices Civils de Lyon Lyon France

2. Department of Cardiology, French Referral Centre for Cardiac Amyloidosis, Cardiogen Network GRC Amyloid Research Institute, DHU A‐TVB, InsermU955, Henri Mondor Teaching Hospital, APHP 51 Avenue Marechal de Lattre de Tassigny Creteil 94000 France

3. Department of Biochemistry Henri Mondor Teaching Hospital, APHP Creteil France

4. Department of Haematology Henri Mondor Teaching Hospital, APHP Creteil France

5. Department of Pathology Henri Mondor Teaching Hospital, APHP Creteil France

6. Department of Genetics Henri Mondor Teaching Hospital, APHP Creteil France

7. Department of Immunobiology Henri Mondor Teaching Hospital, APHP Creteil France

8. Department of Nephrology Henri Mondor Teaching Hospital, APHP Creteil France

Funder

Vifor Pharma

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine